Brief: T. Rowe Price Associates, Inc Reports Passive Stake Of 19.99% In Tenax Therapeutics Inc As Of August 31, 2024- SEC Filing

Tenax Therapeutics

10/09/2024 23:12

Tenax Therapeutics Inc  TENX.O :
    * T. ROWE PRICE ASSOCIATES, INC REPORTS PASSIVE STAKE OF
19.99% IN
TENAX THERAPEUTICS INC AS OF AUGUST 31, 2024- SEC FILING

Source text for Eikon:  ID:n0001897612-24-001393 
Further company coverage:  TENX.O